Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05348317 · ClinicalTrials.gov registry record · NA
Developing a Telehealth Model to Improve Treatment Access for Rural Veterans With Substance Use Disorders
A NA study of Substance Use Disorders and Substance Use, sponsored by VA Office of Research and Development.
- Active
- Registry status
- NA
- Development phase
- 25
- Enrollment target
- 1
- Study location
NCT05348317: Active NA study of Substance Use Disorders and Substance Use, sponsored by VA Office of Research and Development.
NCT05348317 is a NA study of Substance Use Disorders and Substance Use that is active but no longer recruiting, run by VA Office of Research and Development. The registered enrollment target is 25 participants, below the 500-participant average among 93 other Substance Use Disorders trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05348317, a NA study of Substance Use Disorders and Substance Use, is active but no longer recruiting, sponsored by VA Office of Research and Development.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
This project will pilot-test and obtain stakeholder input on a telehealth-delivered substance use disorder (SUD) care model (with initial engagement and ongoing MI-CBT treatment) with the goal of increasing treatment utilization and improving outcomes for rural and non-rural Veterans with SUDs.
Primary Outcome
Percent (%) of participants engaging in the intervention (at least 3 completed sessions)
Conditions Studied
Interventions
- BEHAVIORAL VetReach
Study Locations (1)
Michigan
- VA Ann Arbor Healthcare System, Ann Arbor, MI - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2022-05-19 |
| Est. Completion | 2026-09-30 |
| Phase | NA |
What the registry record for NCT05348317 still lists
NCT05348317 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 500-participant average among 93 other Substance Use Disorders trials with a reported enrollment target (95% lower).
The record links to 4 conditions, with Substance Use Disorders appearing as the primary indexed condition, and to 1 intervention - of which VetReach is the first listed.
NCT05348317 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT05348317 about?
NCT05348317 is a clinical study titled "Developing a Telehealth Model to Improve Treatment Access for Rural Veterans With Substance Use Disorders". This project will pilot-test and obtain stakeholder input on a telehealth-delivered substance use disorder (SUD) care model (with initial engagement and ongoing MI-CBT treatment) with the goal of increasing treatment utilization and improving outcomes for rural and non-rural Veterans with SUDs.
What is the current status of trial NCT05348317?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 25 participants. The study started on 2022-05-19. Estimated completion is 2026-09-30.
What conditions does trial NCT05348317 study?
This clinical trial studies the following conditions: Substance Use Disorders, Substance Use, Veterans, Substance Dependence.
What interventions are being tested in trial NCT05348317?
The interventions under investigation include: VetReach (BEHAVIORAL).
Who is sponsoring clinical trial NCT05348317?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05348317 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Substance Use Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05348317's enrollment target sits among peer trials
25 83rd of 93 higher than 11 of 93 other Substance Use Disorders trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Substance Use Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Supporting Treatment Access and Recovery Through Linkage and Support
RECRUITING · NA
-
Development OF A Novel Peer Recovery Supporter Training Platform
RECRUITING · NA
-
Project I Test: Implementing HIV Testing in Opioid Treatment Programs
RECRUITING · NA
-
Testing Strategies to Improve Substance Misuse Prevention Research Use in State Policy Contexts
RECRUITING · NA
-
Families Left Behind
RECRUITING · NA
-
Trauma Screening/Referral and Interpersonal Violence Prevention for Women with Substance Use Disorders
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI